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Abstract: Objective: Alcohol and tobacco are the two major established environmental factors 
associated with squamous cell carcinoma of the esophagus (ESCC). However, the prevalence of these 
exposures differs substantially between men and women. Moreover, the prevalence of smoking has 
declined in recent years, whereas per capita consumption of alcohol has remained steady in both sexes. 
Quantifying the burden of ESCC attributable to these causal factors is necessary to inform potential 
preventive strategies.  
Methods: We estimated the population attributable fraction (PAF) of ESCC due to smoking and alcohol, 
using data from an Australian population based case-control study (305 ESCC cases, 1554 controls).  
Results: Estimated PAF for ESCC were 49% (95%CI: 38-60) and 32% (95%CI: 25-40) due to smoking 
and heavy alcohol consumption respectively. More than 75% of the ESCC burden in men could be 
attributed to smokers with heavy alcohol consumption. The highest burden was among ≥30 pack years 
smokers who also consumed alcohol heavily (>17 drinks/week); this differed significantly between 
men (PAF 36%, 95%CI 29-44) and women (PAF 5%, 95%CI 2-10). Among women only, low intakes of 
fruit and vegetables accounted for about 9% of the ESCC burden.  
Conclusion: The burden of ESCC attributable to smoking combined with heavy alcohol consumption is 
remarkably high in men. In women, the burden of ESCC due to these factors is lower, and poor 
nutrition may also play a role. 
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INTRODUCTION 
Esophageal squamous cell carcinoma (ESCC) is 2 to 4 fold more common in males 
than females in Western countries such as the US and Australia[1]. In these countries 
ESCC has been largely attributed to smoking and alcohol, the two strongest risk 
factors for ESCC.[2-4] Women typically have lower prevalence of exposure to these 
agents, yet little is known about the sex-specific associations of smoking and alcohol 
with ESCC. To quantify the potential scope for preventing this disease, we have 
computed population attributable fractions of ESCC associated with the key causal 
factors.  We extend previous analyses [5-7] by calculating the burden of ESCC 
attributable to alcohol and tobacco, independently as well as in combination, while 
adjusting for other potential confounders. Moreover, we have calculated these 
measures for both sexes separately.  
 
METHODS 
Study participants 
The study methods of the Australia-wide population-based case-control study have 
been described previously.[8] Eligible cases were people aged 18-79 years, living in 
Australia, with a histologically confirmed primary invasive cancer of the esophagus or 
gastro-esophageal junction diagnosed between July 1, 2002 (July 1, 2001 in 
Queensland) and June 30, 2005. Cases were recruited through either major treatment 
centers or state cancer registries. Of the 1,577 patients with esophageal cancer invited 
to participate in the study (1,191 through clinics and 386 through cancer registries), 
1102 patients (70%) returned a completed questionnaire; 8 case patients were deemed 
ineligible on later review and excluded. Of the 364 EAC, 425 GEJAC and 305 ESCC 
eligible patients, these analyses include 305 ESCC patients.  
*Manuscript
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Controls were randomly selected from the national electoral roll and were frequency 
matched by age (in 5-year age bands) and state of residence to the case group. Of 
3,258 potentially eligible control participants who were contacted and invited to 
participate (646 were un-contactable and deemed ineligible), 175 were excluded 
because they were deceased (16), too ill (61), or unable to communicate in English 
(98), and 41 were lost to follow-up between initial contact and participation. Of the 
3,042 remaining controls, 1,680 (55%) accepted. Completed questionnaires were 
returned by 1,580 controls (49% of all potentially eligible controls). 
 
The study was approved by the ethics committees of the Queensland Institute of 
Medical Research and all participating hospitals and cancer registries. 
 
Exposure measurement 
Information was collected using a self-administered questionnaire, which included 
questions about demographic, medical, hormonal, reproductive, diet, family history, 
and other potential risk factors. Exposures were assessed before a reference date, 
defined as 1 year before the date of diagnosis (or date of first approach for controls), 
because more recent exposures in cases could have been influenced by the presence of 
subclinical disease. Detailed questions about past and current smoking habits asked 
participants whether, over their whole life, they had ever smoked more than 100 
cigarettes, cigars, or pipes; positive responses elicited further questions about the ages 
at which they started and stopped smoking and about typical daily consumption, 
overall and for each decade of their life. Current smokers and ex-smokers were 
defined by their smoking status at their reference age (1 year prior to age at diagnosis 
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for cases, age at study participation for controls). For each participant a decade-
specific smoking dose was calculated in pack-years as the product of the average 
number of cigarettes smoked per day/20, the number of days per week smoked and 
the total number of years smoked within that decade. Lifetime cumulative quantity of 
tobacco smoked (or total pack years) was then calculated by summing up the decade 
specific pack-years. 
 
Participants were asked a series of detailed questions about past and current alcohol 
consumption.  Participants were asked whether they currently drank alcohol, were 
life-long non-drinkers, or used to drink alcohol in the past but had stopped; positive 
responses elicited further questions about the age at which they first started and 
stopped drinking alcohol and typical weekly consumption at different time periods 
(20–29 years, 30–49 years, and 50 years and older). The typical weekly intake for 6 
classes of alcoholic beverages (reduced-alcohol beer, regular beer, white wine, red 
wine, port/sherry, and spirits/liqueurs) was recorded on an ordinal scale as none, less 
than 1, 1, 2–4, 5–6, 7–13, 14–20, 21–27, and 28 or more drinks per week.  The total 
weekly alcohol consumption was calculated by summing the average weekly 
consumption of all beverages by the standard drink volume and alcohol content by 
weight(in grams of alcohol) for each age interval and then for total lifetime. Average 
weekly consumption over adult lifetime was calculated by dividing the total lifetime 
consumption by the number of weeks in life starting from age 20 to the reference age. 
Our previous analyses of these data have shown a threshold for alcohol consumption, 
whereby those drinking >17 drinks per week have significantly higher risks of ESCC 
than those drinking lesser amounts.[2-4] Thus, for the analyses presented here, we 
dichotomized participants into low to moderate drinkers (≤17 drinks/week) and heavy 
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drinkers (>17 drinks per week) for both men and women. We combined non-drinkers 
with low to moderate drinkers as we have previously observed no significant 
difference in the magnitude of associations between non-drinkers and light to 
moderate drinkers.[3] 
 
Participants self-reported height and weight one year ago. BMI, calculated as weight 
in kilograms divided by height in meters squared, was classified using the World 
Health Organization definitions of obesity (underweight: <18.5; normal weight: 18.5–
24.9; overweight: 25–29.9; class I obesity: 30–34.9; class II obesity: 35–39.9; and 
class III obesity: ≥40 kg/m2) [9]. Due to small numbers in the underweight and class 
III obesity categories, we collapsed the two highest and lowest categories for these 
analyses. Participants were asked about frequency of heartburn (‘a burning pain 
behind the breastbone after eating’) or acid reflux (‘a sour taste from acid or bile 
rising up into the mouth or throat’) 10 years before diagnosis, and frequency of 
aspirin or nonsteroidal anti-inflammatory drug (NSAID) use in the past 5 years. 
Dietary data were obtained on a subsample of 91% participants using a food 
frequency questionnaire as described previously.[10] Briefly, we asked participants 
about their consumption in the previous year (controls) and the year before diagnosis 
(cases). In addition to the itemized foods, two summary questions on total number of 
serves of fruits and vegetables consumed per day were assessed. We categorized 
participants into two categories of adequate (at least 2 serves of fruits and 5 serves of 
vegetables daily) and inadequate (less than 2 serves of fruits or 5 serves of vegetables 
daily) consumption according to NHMRC dietary guidelines for all Australians.[11]  
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Statistical methods 
 
To calculate adjusted population attributable risks with 95% confidence intervals we 
used the method of Bruzzi et al.[12] which uses adjusted ORs derived from 
unconditional logistic regression models as well as the prevalence of the risk factors 
in the study cases. This method takes into account multiple levels of exposure and 
controls for confounding by other factors. Confidence intervals for the model-based 
PAFs were calculated using logit transformation as described by Benichou and Gail 
[13]. Firstly, PAFs were calculated for individual risk factors for all cases and 
separately for men and women. We estimated relative risks associated with each 
stratum of smoking (smoking status and pack-years smoked) and alcohol consumption 
(low to moderate vs heavy) adjusting for age, sex, education (High school or less, 
technical college, trade certificate and university) frequency of reflux symptoms 
(never, less than weekly and weekly or more), frequency of aspirin or NSAID use 
(never, less than weekly and weekly or more) and BMI. Missing data for the 
confounding factors were included in the analysis as a separate category. For 
smoking, the ‘never’ category was used as the reference; for alcohol consumption, 
low to moderate consumption was used as the reference category. We then computed 
partial PAFs for combinations of smoking (never’, ‘ex-smoker’, ‘current smoker’ or 4 
groups of pack years smoked) and alcohol consumption (low to moderate, heavy). 
The partial PAF is calculated by cross-classifying the two exposures and setting the 
lowest level as a reference category. The partial PAF for all combinations of the 
cross-classified exposure variables sums to PAF. The reference group for the 
combined smoking and alcohol exposures was never smokers who reported low to 
moderate alcohol consumption. These were computed for the total sample (i.e. both 
sexes combined) adjusted for age, sex, education, frequency of aspirin or NSAID use, 
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and frequency of heartburn or reflux. We then repeated the analyses separately for 
males and females. Finally, in a subset of participants for whom complete data 
including dietary data were available (172 cases and 1259 controls), we conducted 
combined analyses of smoking, alcohol and intake of fruits & vegetables to estimate 
the burden of disease that could be attributed to these factors. All analyses were 
conducted using the Interactive Risk Assessment Program (IRAP) Version 2.2 
(available from the US National Institute of Health; 
http://dceg.cancer.gov/bb/tools/irap). Statistical significance was determined at 
α=0.05, and all tests for statistical significance were two-sided. We compared the 
PAFs between men and women for each exposure using the independent t test. 
 
 
RESULTS 
The characteristics of study cases and controls are presented in Table 1. Of the 305 
cases of ESCC, 174 (57%) were men and 131 (43%) women. Both male and female 
cases were more likely than controls to be ever-smokers. Heavy alcohol consumption 
was reported by 70% of male cases but only 12% of female cases (p<0.001). Male 
cases were more likely than female cases to be ever-smokers (88% vs 56%; p<0.001). 
 
The PAFs for squamous cell carcinoma of the esophagus for the major causal factors, 
and adjusted for the other factors, are presented in Table 2. For all cases combined, 
smoking contributed the highest PAF (49%, 95 % CI: 38, 60), which was greater for 
men than women (66% vs 35% respectively; p=0.002), reflecting the higher 
prevalence of ever-smoking in male cases (Supplementary Table 1). The PAF for 
heavy alcohol consumption was also significantly higher for men than women (48% 
vs 8% respectively; p<0.001); again this reflected the higher prevalence of heavy 
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alcohol consumption in men (70%) than women cases (12%), as well as the lower 
relative risks associated with high alcohol consumption in women compared to men 
(Supplementary Table1). Adjusting for fruit and vegetable consumption did not make 
any material difference to the estimates of PAFs for smoking and alcohol in the subset 
with dietary data.  
 
Partial PAFs for combinations of alcohol consumption and cumulative smoking dose, 
as measured by pack-years, are presented in Table 3. In this study, the total fraction of 
ESCC attributable to these two factors was 58% (95 % CI: 49, 67), and this fraction 
was significantly and substantially higher for men than women (78% vs 38%; 
p<0.001). Overall, the highest partial fraction, accounting for approximately one 
quarter of all ESCC cases, was attributable to heavy smokers who were also heavy 
consumers of alcohol (PAF 22%, 95 % CI: 18, 28). The burden of ESCC attributable 
to this combination of factors differed notably between the sexes; heavy consumption 
of tobacco and alcohol accounted for 36% of the ESCC cases in men, but only 5% in 
women (Table3). We found that current and past smoking along with heavy drinking 
contributed almost equally to the total PAF (Supplementary Table 2). Although the 
estimated risk of ESCC for current smokers is much larger than that for past smokers, 
the high prevalence of past smokers in the population (Supplementary Table 3) 
accounted for the higher burden of disease in this subgroup. The partial PAFs for 
women were almost uniformly distributed among smokers irrespective of whether 
they were heavy drinkers or not.  
 
To explore further the burden of ESCC not explained by the combination of smoking 
and alcohol consumption (22% in men, 62% in women), we examined the additional 
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contribution of low intakes of fruits and vegetables to estimates of PAF. To minimize 
the numbers of terms included in these final models, we fitted terms for smoking 
(‘ever’ vs ‘never’), alcohol consumption (‘heavy’ vs ‘none to moderate) and fruit and 
vegetable intake (‘sufficient = at least 2 serves of fruits and 5 serves of vegetables 
daily’ vs ‘insufficient’). Although the estimates of PAFs were not directly comparable 
after adding fruits and vegetables consumption (due to dietary data only being 
available for a subsample of participants), our estimates of total PAF for combination 
of three exposures smoking, alcohol and fruit and vegetable intake increased notably 
for women (38% to 49%). Women, who were never smokers and not heavy drinkers 
but reported having low intakes of fruits and vegetables accounted for an additional 
9% of the total PAF. No such effect of fruit and vegetable consumption was observed 
for men.  
 
DISCUSSION 
We have estimated the PAFs of squamous cell carcinoma of the esophagus for 
smoking and alcohol consumption individually, as well as in combination. The PAF 
estimates the proportion of disease in the population which can be attributed to a risk 
factor or groups of risk factors, and thus estimates the proportion of cases that might 
be avoided if those factors were eliminated from the population. We focused our 
analysis on smoking and alcohol; two modifiable exposures that are widely held to be 
causal for ESCC.[2, 14] We also included a measure of fruit and vegetable 
consumption as low intake has been shown to confer increased risks of ESCC in 
populations where smoking and alcohol are less prevalent.[15]  
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In this study, we estimated that smoking and alcohol consumption together accounted 
for 60% of ESCC cases overall. Importantly, these two factors accounted for more 
than three quarters of cases among men, but fewer than half of the cases among 
women.  Smoking individually accounted for the greatest proportion of ESCC in both 
sexes. Among cases, both tobacco and high levels of alcohol consumption were 
higher in men than women. Alcohol and tobacco act with a multiplicative effect on 
the risk of ESCC,[2, 16] and the apparent differences in attributable fractions between 
men and women appear, in part, to reflect this synergistic effect on risk. The 
possibility of differences in ESCC biology between men and women cannot be ruled 
out however. Our analyses assume that the effects of alcohol on ESCC risk are the 
same for men and women, although we have shown previously that this may not be 
the case. We therefore re-analyzed our data using our previously reported lower cut-
point of 10 units/week for women. Using this lower definition of harmful drinking for 
women, the relative risk of ESCC was slightly lower, but the prevalence of exposure 
increase by approximately 15%. The overall impact of this lower cut-point would be 
to increase the PAF estimate for alcohol in women from 7.9% to 15.4%. Moreover, 
we identified a subgroup of women with ESCC who did not smoke and did not drink 
heavily – a group who would be expected to be at lower than average risk for this 
disease. Among this group however, the proportion of women with cancer who 
reported low intakes of fruits and vegetables was higher than non-smoking, light-
drinking controls. Together, these observations point to nutritional deficiencies as 
possibly contributing to a proportion of the occurrence of ESCC in women. Poor 
nutrition has been suggested to be associated with ESCC in high incidence regions 
such as Iran where the prevalence of smoking and alcohol is not as high as western 
countries.[15] Hormonal factors may play a role; previous studies have reported a 
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reduced risk of ESCC amongst users of hormonal replacement therapy[17] and also 
oral contraceptives[18] compared to non-users. Although infections with Human 
Papillomavirus or Helicobacter pylori have been suggested previously as factors 
possibly accounting for some cases of ESCC, recent analyses from this study 
population provide no support for such mechanisms.[19, 20] 
 
Only three sex-specific analyses for ESCC have been reported previously in the 
literature, and our estimates of PAF are reasonably similar to those. In an Italian case-
control study, Negri and colleagues reported PAFs for smoking of 32% in women and 
61% in men, and PAFs for high alcohol consumption of 10% in women and 39% in 
men; the overall PAF for the joint effect of the two factors was 40% in women and 
84% in men [7]. Similarly, Castellsague and colleagues with data from a case-control 
study conducted in high risk areas of South America reported PAFs for smoking of 
22% in women and 70% in men, for alcohol consumption of 20% in women and 64% 
in men and, for the combined effect, 29% in women and 90% in men [5]. A recent 
European multicenter case-control study also observed similar disparity in the 
estimated population attributable risk due to smoking and alcohol between men and 
women in all upper aerodigestive tract cancers.[21]  
 
Strengths of our study include the population-based design, large number of cases and 
detailed information on multiple exposures. A limitation was the relatively low 
participation rate among controls (49%) which could have resulted in selection bias 
and an overrepresentation of more health-conscious control participants who are less 
likely to be ever-smokers/heavy consumers of alcohol. This would have the effect of 
over-estimating the PAFs, but would be unlikely to account for the sex-specific 
11 
 
differences we observed. The demographic characteristics and patterns of total and 
type-specific alcohol intakes of our participating controls were similar to the 
participants in the Australian National Health Survey however, a representative 
survey of the Australian adult population conducted in 2004.[22] We have also 
previously explored the potential for selection bias due to non-participation on risk 
estimates for smoking. We  compared ORs derived from self-reported data from 
participating controls with ORs derived using imputed data for non-participating 
controls;  we observed only a modest level of attenuation in risk estimates among 
current smokers.[23] 
 
Lastly, these estimates of PAF assume a causal association between each factor and 
ESCC, and that removal of exposure to these factors alone will lead to a decline in the 
incidence of this cancer. It is possible however, that there are other causal factors that 
are correlated with the factors examined here, and which would continue to exert a 
force of morbidity even if these primary factors were removed.  
In summary, our findings suggest that lifestyle modifications, particularly the 
cessation of tobacco smoking and decreased intake of alcohol would lead to a 
reduction in the incidence of ESCC, although the impact of such a change at the 
population level would be much larger amongst men than women. Amongst women, 
only a small percentage of cases are attributable to smoking and high alcohol 
consumption; the majority of female cases are presumably attributable to other 
factors. 
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Table1. Distribution of demographic and lifestyle characteristic of population controls and esophageal cancer cases  
Variables 
Controls ESCC 
Women Men P  
value 
Women Men P 
value N (%) N (%) N (%) N (%) 
Age (Mean, SD) 56.7 (12.8) 62.5 (10.5)  65.8 (9.0) 64.0 (9.5)  
Age groups       
30-39 52 (9.6%) 29 (2.8%)  0 (0.0%) 2 (1.1%)  
40-49 110 (20.4%) 90 (8.7%)  7 (5.3%) 10 (5.7%)  
50-59 142 (26.3%) 267 (25.7%)  29 (22.1%) 43 (24.7%)  
60-69 147 (27.2%) 389 (37.4%)  43 (32.8%) 64 (36.8%)  
70+ 89 (16.5%) 265 (25.5%) <0.001 52 (39.7%) 55 (31.6%) 0.50 
Further Education       
None  273 (50.6%) 373 (36.0%)  83 (63.4%) 90 (52.3%)  
Technical College/diploma 151 (28.0%) 196 (18.9%)  26 (19.8%) 27 (15.7%)  
Trade certificate/apprenticeship 43 (8.0%) 298 (28.7%)  13 (9.9%) 38 (22.1%)  
University degree 72 (13.4%) 170 (16.4%) <0.001 9 (6.9%) 17 (9.9%) 0.03 
Smoking status       
Current smoker 72 (13.4%) 136 (13.3%)  32 (24.4%) 61 (35.5%)  
Ex-Smoker 142 (26.4%) 498 (48.8%)  42 (32.1%) 91 (52.9%)  
Non-Smoker 323 (60.1%) 387 (37.9%) <0.001 57 (43.5%) 20 (11.6%) <0.001 
Body Mass Index a year ago       
18-24.9 234 (43.7%) 336 (32.6%)  81 (66.4%) 85 (51.2%)  
25-29.9 171 (32.0%) 502 (48.7%)  25 (20.5%) 55 (33.1%)  
Table
2 
 
   
Variables 
Controls ESCC 
Women Men P  
value 
Women Men P 
value N (%) N (%) N (%) N (%) 
30-34.9 71 (13.3%) 155 (15.0%)  9 (7.4%) 19 (11.4%)  
35+ 59 (11.0%) 38 (3.7%) <0.001 7 (5.7%) 7 (4.2%) 0.03 
Frequency of heartburn or acid 
reflux 
      
Never 260 (48.3%) 438 (42.5%)  70 (55.1%) 73 (42.0%)  
Less than Weekly 217 (40.3%) 469 (45.5%)  28 (22.0%) 51 (29.3%)  
Weekly or more 61 (11.3%) 123 (11.9%) 0.08 29 (22.8%) 50 (28.7%) 0.07 
Physical activity index       
Sedentary 103 (19.3%) 228 (21.9%)  34 (26.6%) 53 (30.8%)  
Mild activity 222 (41.6%) 409 (39.3%)  37 (28.9%) 55 (32.0%)  
Moderate activity 209 (39.1%) 403 (38.8%) 0.44 57 (44.5%) 64 (37.2%) 0.39 
Lifetime alcohol consumption       
None to moderate drinkers (≤17 
drinks/week) 
518 (96.3%) 667 (64.4%)  113 (87.6%) 53 (30.6%)  
Heavy drinkers (>17 drinks/week) 20 (3.7%) 369 (35.6) <0.001 35 (12.4%) 120 (69.4%) <0.001 
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Table2. Adjusted odds ratios, population attributable fraction (PAF) and 95% confidence intervals (CIs) for smoking and alcohol consumption for 
Squamous cell carcinoma of the esophagus in a population based case-control study of esophageal cancer in Australia (2002-2005). 
   Adjusted population attributable fraction (95% CI)* 
Variables  Odds Ratio (95% CI) Total  Women Men 
Smoking status     
Never smoker 1.0 (Reference) - - - 
Ex-smoker 2.3 (1.6, 3.3) 24.2 (16.1, 34.7) 14.4 ( 5.9, 31.2)† 36.4 (24.7, 50.0) 
Current smoker 4.9 (3.2, 7.4) 24.7 (19.2, 31.1) 20.4 (13.4, 29.8) 29.8 (22.2, 38.7) 
Total PAF due to ever smoking 2.9 (2.1, 4.1) 48.9 (37.8, 60.0) 34.9 (22.1, 50.4)† 66.1 (49.5, 79.6) 
Total pack-years smoked     
Never 1.0 (Reference) - - - 
Less than 15 pack-years 1.9 (1.3, 2.9) 9.3 (4.9, 17.2) 11.9 (4.7, 27.0) 9.1 (4.2, 18.4) 
15 to 30 pack-years 3.5 (2.2, 5.5) 13.1 (8.9, 19.0) 10.0 (4.9, 19.1) 16.7 (10.7, 25.0) 
30 or more pack-years 4.1 (2.7, 6.2) 27.4 (21.0, 34.9) 12.8 (7.1, 22.1)† 41.6 (31.8, 52.1) 
Lifetime Alcohol Consumption     
None to moderate drinkers (≤17 drinks/week) 1.0 (Reference) - - - 
Heavy drinkers (>17 drinks/week) 3.3 (2.4, 4.7) 31.7 (24.5, 39.9) 7.9 (3.5, 16.9)† 48.4 (36.2, 60.8) 
*PAF adjusted for age, sex, education, frequency of reflux symptoms, frequency of NSAID or aspirin use and body mass index (cases=300, controls=1558).  
†P value <0.05 comparing PAF between male and female. 
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Table3. Partial population attributable fraction (PAF) and 95% confidence intervals (CIs) for combination of smoking (in pack-years) and alcohol 
for Squamous cell carcinoma of the esophagus in a population based case-control study of esophageal cancer in Australia (2002-2005).  
Smoking status Alcohol consumption 
Partial population attributable fraction (95% CI) 
All Women Men 
Never smoker 
None  to moderate  drinkers 
(≤17 drinks/week) Reference Reference Reference 
 
Heavy drinkers 
(>17 drinks/week) 2.7 (1.4, 5.0) 1.9 (0.5, 6.7) 3.1 (1.4, 6.5) 
<15 pack-years 
None to moderate drinkers 
(≤17 drinks/week) 5.2 (2.2, 11.8) 10.7 (4.3, 24.4) 3.3 (1.1, 9.5) 
 
Heavy drinkers 
(>17 drinks/week) 4.8 (2.9, 7.9) 1.8 (0.6, 5.9) 7.2 (4.0, 12.6) 
15-30 pack-years 
None to moderate drinkers 
(≤17 drinks/week) 5.4 (3.1, 9.0) 8.7 (4.2, 17.4) 3.4 (1.5, 7.4) 
 
Heavy drinkers 
(>17 drinks/week) 9.2 (6.3, 13.2) 1.4 (0.3, 5.5) 15.3 (10.4, 22.0) 
30 or more pack-years 
None to moderate drinkers 
(≤17 drinks/week) 8.5 (5.6, 12.6) 8.8 (4.6, 16.3) 9.2 (5.5, 14.8) 
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Heavy drinkers 
(>17 drinks/week) 22.4 (17.8, 27.9) 4.9 (2.3, 10.3) 36.2 (28.8, 44.4) 
Total PAF attributed by the combination of two factors 58.2 (49.1, 66.7) 38.2 (25.9, 52.1) 77.7 (65.5, 86.5) 
PAR for all adjusted for age, sex, further education, frequency of aspirin use, frequency of heartburn or reflux and body mass index (cases=300, 
controls=1558). †P value <0.05 comparing PAF between male and female. 
Supplementary Table1. Odds Ratios and prevalence of exposure among cases for the exposures and their PAFs described in Table 2. 
Variables 
All Women Men 
Prevalence of 
exposure among 
cases (%) 
Odds Ratio 
(95% CI) 
Prevalence of 
exposure among 
cases (%) 
Odds Ratio 
(95% CI) 
Prevalence of 
exposure among 
cases (%) 
Odds Ratio 
(95% CI) 
Smoking status       
Never smoker - 1.0 (Reference) - 1.0 (Reference) - 1.0 (Reference) 
Ex-smoker 43.3 2.3 (1.6, 3.3) 31.0 1.9 (1.1, 3.3) 52.6 3.2 (1.9, 5.7) 
Current smoker 31.0 4.9 (3.2, 7.4) 24.8 5.6 (2.8, 11.0) 35.7 6.0 (3.3, 11.1) 
Total PAF due to ever smoking 74.3 2.9 (2.0, 4.1) 55.8 2.7 (1.6, 4.4) 88.3 4.0 (2.3, 6.8) 
Total pack-years smoked       
Never - 1.0 (Reference) - 1.0 (Reference) - 1.0 (Reference) 
Less than 15 pack-years 19.7 1.9 (1.3, 2.9) 24.8 1.9 (1.1, 3.5) 15.8 2.3 (1.2, 4.5) 
15 to 30 pack-years 18.3 3.5 (2.2, 5.5) 14.0 3.5 (1.7, 7.3) 21.6 4.3 (2.3, 8.2) 
30 or more pack-years 36.3 4.1 (2.7, 6.2) 17.0 4.0 (1.9, 8.5) 50.9 5.5 (3.1, 9.8) 
Alcohol Consumption       
Low to moderate drinkers (≤17 
drinks/week) - 1.0 (Reference) - 1.0 (Reference) - 1.0 (Reference) 
Heavy drinkers (>17 
drinks/week) 45.3 3.3 (2.4, 4.7) 12.4 2.8 (1.2, 6.1) 70.2 3.2 (2.2, 4.7) 
       
Additional files
Supplementary Table 2. Partial population attributable risk (PAR) and 95% confidence intervals (CIs) for combination of smoking and 
alcohol for Squamous cell carcinoma of the oesophagus in a population based case-control study of oesophageal cancer in Australia 
(2002-2005).  
Smoking status Alcohol consumption** 
Partial population attributable risk (95% CI) 
All Women Men 
Never smoker  
None to moderate (≤17 
drinks/week) Reference Reference Reference 
 Heavy (>17 drinks/week) 2.8 (1.5, 5.1) 2.0 (0.6, 7.0) 3.2 (1.5, 6.7) 
Ex-smoker  
None to moderate (≤17 
drinks/week) 10.8 (6.3, 17.9) 12.6 (5.2, 27.4) 11.5 (6.5, 19.7) 
 Heavy (>17 drinks/week) 17.7 (13.5, 23.0) 16.0 (10.1, 24.4) † 29.9 (22.7, 38.2) 
Current smoker  
None to moderate (≤17 
drinks/week) 8.2 (5.6, 12.1) 3.1 (1.2, 7.8) † 3.3 (1.5, 7.0) 
 Heavy (>17 drinks/week) 18.9 (14.8, 24.0) 5.1 (2.4, 10.5) † 29.7 (23.0, 37.4) 
Total PAF attributed by the combination of two factors 58.5 (49.5, 67.0) 38.7 (26.4, 52.6) † 77.6 (65.3, 86.4) 
PAF for all adjusted for age, sex, further education, frequency of NSAID or aspirin use, frequency of heartburn or reflux and body mass index (cases=300, controls=1558).  
 
 Supplementary Table3. Odds Ratios and prevalence of exposure among cases for exposure combinations described in supplementary 
table2. 
Smoking 
status Alcohol consumption 
All Women Men 
Prevalence 
of exposure 
among 
cases (%) 
Odds Ratio 
(95% CI) 
Prevalence of 
exposure 
among cases 
(%) 
Odds Ratio 
(95% CI) 
Prevalence of 
exposure among 
cases (%) 
Odds Ratio 
(95% CI) 
Never smoker  
None to moderate (≤17 
drinks/week) Reference 
Reference 
- - - - 
 
Heavy (>17 
drinks/week) 4.0 3.1 (1.5, 6.3) 3.1 6.3 (1.4, 29.2) 4.7 2.6 (1.0, 6.8) 
Ex-smoker  
None to moderate (≤17 
drinks/week) 22.3 2.2 (1.5, 3.3) 27.1 2.2 (1.3, 3.8) 18.7 2.8 (1.4, 5.8) 
 
Heavy (>17 
drinks/week) 21.0 5.5 (3.4, 8.8) 3.9 2.2 (0.7, 7.4) 33.9 6.8 (3.5, 13.4) 
Current smoker  
None to moderate (≤17 
drinks/week) 10.7 3.1 (1.9, 5.2) 19.4 5.3 (2.6, 10.7) 4.1 2.4 (0.9, 6.4) 
 
Heavy (>17 
drinks/week) 20.3 19.9 (11.5, 34.3) 5.4 36.6 (7.4, 181.5) 31.6 19.0 (9.3, 38.8) 
 
 
